Calls for proposals continuously open all year round
Open Call 1 January 2022 - 31 December 2022
Researchers are required to contact OmicsTech to discuss the project feasibility, design, sample requirements, tentative calendar and cost.
Two access modalities are considered:
- Small/Medium-scale projects
- Large-scale projects, that must be evaluated by an external committee
Examples of large-scale projects are:
- WGS human projects that include more than 50 samples
- WES and RNA-seq projects that include more than 100 samples
- De novo assembly and annotation projects that include more than 5 samples
- Single Cell analysis projects that include more than 30 samples
Metabolomics, Proteomics and Multiomics
Projects with more than 24 samples for proteome quantification, characterization post-translational modifications, identification of protein interactions can be considered as large-scale. Exceptionally, projects with less samples, but which require a large fraction of resources (time/material) of the infrastructure will also be considered large-scale.
OmicsTech will issue a service contract for the agreed experiments that has to be formally accepted by the user before starting any experimental procedure.
ONLY projects selected as large-scale omics projects will be required to fill in the OmicsTech Access Form available at:
OmicsTech offers competitive open access to researchers working at national or international R&D institutions, hospitals or companies under the following policy guidelines.
OmicsTech assists researchers in Genomics, Metabolomics and Proteomics providing expertise in project design, omics technologies, data analysis and results interpretation.
The OmicsTech services are available on a fee-for-service basis.
Calls for projects are continuously open.
All services are performed by OmicsTech technical staff (remote).
All experiments receive the same priority.
Researchers participating in the Spanish National R+D+i Plan should formally express their intention to use OmicsTech during the application process.